Nuvasive Total Current Liabilities

Nuvasive (NUVA) currently reports a total current liabilities of $580M as of June 2023. That compares with $700M in the prior-year period — down 16.9% year over year. Use the charts on this page to explore Nuvasive's total current liabilities history and peer comparisons.

Nuvasive's total current liabilities decreased from $700M to $580M — a 16.9% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nuvasive reported $580M in total current liabilities as of June 2023. That compares with $700M in the prior-year period — down 16.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $580M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nuvasive, and consider following NUVA for alerts when major investors trade the stock.

Nuvasive is classified in the Healthcare sector. On total current liabilities, it currently shows $580M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NUVA with unrelated industries.